Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
Read More
2 minute read

What’s Going On With Palantir Stock Ahead Of Earnings?

By Erica Kollmann
February 2, 2:34 PM
Palantir is set to release its fourth-quarter and fiscal year 2023 financial results after the market close on Monday and will host a webcast to discuss the results at 5:00 p.m. ET the same day. According to estimates from Benzinga Pro, Palantir is expected to report fourth-quarter earnings of 8 cents per share and quarterly revenue of $602.4 million.

PLTR

Read More
1 minute read

Why Intelligent Bio Solutions Shares Are Soaring

By Erica Kollmann
February 2, 12:16 PM
Intelligent Bio Solutions shares are moving on very heavy trading volume with more than 46.4 million shares already traded in the session. According to data from Benzinga Pro, the stock has a float of only 726,316 shares after the stock effected a 1-for-12 reverse split on Monday. Intelligent Bio Solutions shares have a significant amount of short interest. 45.66% of shares being sold short which, when combined with the heavy trading volume, may be contributing to the stock's large move on Friday.

INBS

Read More
1 minute read

What’s Going On With Bitcoin Miners Marathon Digital and Hut 8 Stock?

By Erica Kollmann
February 2, 12:11 PM
Marathon Digital and Hut 8 made separate announcements stating an agreement was signed on Jan. 30 that will terminate Hut 8 operator of these sites and transition the operational responsibilities to Marathon. Hut 8 will continue to provide managed services and conduct self-mining activities at the two mining sites through April 30. A termination fee of $13.568 million will be paid to Hut 8 within 30 days of the termination date.

BTC

Read More
1 minute read

Why Cimpress Stock Is Up After Earnings

By Erica Kollmann
February 1, 1:55 PM
Cimpress beat estimated earnings by 72.58%, reporting quarterly earnings of $2.14 per shares versus the analyst consensus estimate of $1.24. The company reported quarterly sales of $921.36 million which beat the analyst consensus estimate of $892.1 million by 3.28% and represents a 9% increase over sales of $845.20 million the same period last year.

CMPR

Read More
2 minute read

What’s Going On With Kiora Pharmaceuticals Stock?

By Erica Kollmann
February 1, 12:57 PM
Kiora Pharmaceuticals also entered into a securities purchase agreement with certain institutional investors, pursuant to which Kiora agreed to issue and sell 15,800,000 shares and warrants for expected aggregate gross proceeds at closing of approximately $15 million and potential future warrant exercise gross proceeds of approximately $30 million.

KPRX

Read More
2 minute read

Why Nextracker Stock Is Soaring After Earnings

By Erica Kollmann
February 1, 11:49 AM
Nextracker reported its third-quarter financials after the bell on Wednesday with blockbuster earnings of 96 cents per share, beating the analyst consensus estimate of 48 cents by 100%. Revenue clocked in at $710.43 million, representing a 38.38% increase over sales of $513.37 million from the same period last year.

NXT